WNT SCIENTIFIC LLC
Rochester, NY · Medtech · Private
PCL/CXCL12 biomaterial scaffold for local delivery of chemokine to promote angiogenesis and fracture healing
- Grants
- $2.9M
- 7 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201820192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Development of Drug Delivery Technology for Stem Cell-Based TMJ Regeneration | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of Drug Delivery Technology for Stem Cell Based TMJ Regeneration | $752,047 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of Drug Delivery Technology for Stem Cell Based TMJ Regeneration | $742,838 | |
| Federal grant | Department of Health and Human Services · Phase I · Small Molecules Promote Tendon Regeneration by Targeting Endogenous Stem Cells | $252,131 | |
| Federal grant | Department of Health and Human Services · Phase I · Innovative medical device to treat nonunion fracture for older adults | $299,428 | |
| Federal grant | Department of Health and Human Services · Phase I · Innovative medical device to treat nonunion fracture for older adults | $299,428 | |
| Federal grant | Department of Health and Human Services · Phase I · Intraarticular injection of Wnt inhibitor for osteoarthritis therapy | $314,363 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1345 | Simulated Inanimate Models LLC | — | $900K |
| 1346 | NOVOPYXIS INC. | — | $856K |
| 1347 | Eliaz Therapeutics, Inc. | — | $850K |
| 1348 | WNT SCIENTIFIC LLC | — | — |
| 1349 | Echopoint Medical Ltd | — | $250K |
| 1350 | Fresenius Medical Care Glendale, LLC | — | $216K |
| 1351 | Moleculera Labs, Inc. | — | $3.4M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.